Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer

American Journal of Surgery

Volumn 176, Issue 6, 1998, Pages 502-509

  Kuerer, Henry M ^a,b   Newman, Lisa A ^a   Buzdar, Aman U ^a   Hunt, Kelly K ^a   Dhingra, Kapil ^a   Buchholz, Thomas A ^a   Binkley, Susan M ^a   Ames, Frederick C ^a   Feig, Barry W ^a   Ross, Merrick I ^a   Hortobagyi, Gabriel N ^a   Singletary, S Eva ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CONFERENCE PAPER; DISSECTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURGICAL DRAINAGE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOADJUVANT THERAPY; PATIENT SELECTION; PROGNOSIS;

EID: 0032433252     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00253-0     Document Type: Conference Paper

References (21)

1. 1. Delena M, Zucali R, Viganotti G, et al. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmocol. 1978;1:53-59.
2. 2. Hortobagyi GN, Blumenschein GR, Spanos W, et al. Multimodal treatment of locoregionally advanced breast cancer. Cancer. 1983;51:763-768.
3. 3. Lippman ME, Sorace RA, Bagley CS, et al. Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. NCI Monogr. 1986;1:156-159.
4. 4. Scholl SM, Fourquet A, Asselain B, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer. 1994;5:645-652.
5. 5. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15:2483-2493.
6. 6. Singletary SE, McNeese MD, Hortobagyi GN. Feasability of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer. 1992;69:2849-2852.
7. 7. Schwartz GF, Birchansky CA, Komarnicky LT, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer. 1994;73:362-369.
8. 8. Bonadonna G, Valagussa P, Brambilla C, et al. Primary chemotherapy in operable breast cancer: eight year experience at the Milan Cancer Institute. J Clin Oncol. 1998;16:93-100.
9. 9. O'Reilly MS, Boehm T, Shing Y, et al. Endostatintin: endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88-277-285.
10. 10. McCready DR, Hortobagyi GN, Kau SW, et al. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg. 1989;124: 21-25.
11. 11. Dhingra K, Singletary E, Strom E, et al. Randomized trial of G-CSF (Filgrastim)-supported dose-intensive neoadjuvant chemotherapy in locally advanced breast cancer. Proc Am Soc Clin Oncol. 1995;14:94. Abstract.
12. th ed. Philadelphia: JB Lippincott; 1993:149.
13. 13. Kaplan EL, Meier P. Nonparamecric estimation from incomplete observations. J Am Stat Assoc. 1958;185:1457-1481.
14. 14. Mantel N. Evaluation of survival data and two row rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50:163-170.
15. 15. Cox DR. Regression models and life-tables. J R Stat Soc. 1972; 34:187-220.
16. 16. Botti C, Vici P, Lopez M, et al. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg. 1995;181:202-208.
17. 17. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. NEJM. 1985;312:674-681.
18. 18. Osborne MP, Ormiston N, Harmer OL, et al. Breast conservation in the treatment of early breast cancer: a 20-year follow-up. Cancer. 1984;53:349-355.
19. 19. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. NEJM. 1995;333: 1444-1455.
20. 20. Brain E, Garrino C, Misset JL, et al. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. Br J Cancer. 1997;75:1360-1367.
21. 21. Rahman ZU, Frye DK, Buzdar AU, et al. Impact of selection receive BCS. Am J Surg. 1998;176:510-514.